Brief: Allergy Therapeutics Posts H1 Rev 34 Mln Stg
28/01/2025 07:51
Jan 28 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS H1 REVENUE GBP 34 MILLION
* ALLERGY THERAPEUTICS: OVERALL SALES FOR FULL YEAR ENDING
ON 30
JUNE 2025 EXPECTED TO EXCEED SALES IN CORRESPONDING PERIOD ENDED
30 JUNE 2024
Source text: ID:nRSb8539Ua
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman